The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients

Código QR

The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients

Akio Nomura,1 Hirotaka Osaki,1 Fumiki Shimada,1 Yasuaki Kuwayama2 1Pharmacovigilance, Quality Compliance Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan; 2Fukushima Eye Clinic, Osaka, Japan Purpose: This study evaluates the effect of tafluprost on visual field progression in normal-tension...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nomura A, Osaki H, Shimada F, Kuwayama Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	MD slope NTG Observational post-marketing study Ophthalmology Visual field RE1-994
Acceso en línea:	https://doaj.org/article/127162fd2fdd4bc388c0968e532bfa93
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long-term progression of visual field defects and related factors in medically treated normal tension glaucoma
por: Yoshikawa K, et al.
Publicado: (2018)

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
por: Inoue K, et al.
Publicado: (2013)

Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
por: Naito T, et al.
Publicado: (2016)

Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost
por: Sacchi M, et al.
Publicado: (2014)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi T, et al.
Publicado: (2012)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda Y, et al.
Publicado: (2016)

Investigation of the association between the GLC3A locus and normal tension glaucoma in Japanese patients by microsatellite analysis
por: M Kamio, et al.
Publicado: (2009)

Association of microsatellite polymorphisms of the GPDS1 locus with normal tension glaucoma in the Japanese population
por: Kayo Nakamura, et al.
Publicado: (2009)

Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
por: Yuya Nomura, et al.
Publicado: (2010)

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
por: Takemoto D, et al.
Publicado: (2017)

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
por: Lanzl I, et al.
Publicado: (2013)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
por: Tsumura T, et al.
Publicado: (2014)

Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects
por: Mizoue S, et al.
Publicado: (2014)

Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
por: Hwang YH
Publicado: (2013)

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
por: Seibold LK, et al.
Publicado: (2014)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
por: Tsumura T, et al.
Publicado: (2015)

Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma
por: Perdicchi A, et al.
Publicado: (2016)

Optic disc topography in Malay patients with normal-tension glaucoma and primary open-angle glaucoma
por: Adlina AR, et al.
Publicado: (2014)

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
por: Ermiş&nbsp;SS
Publicado: (2012)

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
por: Liu Y, et al.
Publicado: (2012)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
por: Tsumura T, et al.
Publicado: (2015)

Serum free fatty acids levels not associated with normal tension glaucoma
por: Kenya Yuki, et al.
Publicado: (2010)

Retinal Sensitivity Thresholds Obtained Through Easyfield and Humphrey Perimeters in Eyes with Glaucoma: A Cross-Sectional Comparative Study
por: Nazareth T, et al.
Publicado: (2020)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Dorota Pozarowska
Publicado: (2010)

Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
por: Yoshikawa K, et al.
Publicado: (2021)

Superior segmental optic nerve hypoplasia accompanied by progressive normal-tension glaucoma
por: Yamazaki Y, et al.
Publicado: (2012)

Incidence of deepening of upper eyelid sulcus after topical use of tafluprost ophthalmic solution in Japanese patients
por: Maruyama K, et al.
Publicado: (2013)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
por: Makoto Aihara
Publicado: (2010)

Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
por: Inoue K, et al.
Publicado: (2014)

Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
por: Inoue K, et al.
Publicado: (2012)

Optic disc size and progression of visual field damage in patients with normal-tension glaucoma
por: Hayamizu F, et al.
Publicado: (2013)

Continuous 24-hour ocular dimensional profile recording in medically treated normal-tension glaucoma
por: Lee JWY, et al.
Publicado: (2015)

Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients
por: Mohammed K El Mallah, et al.
Publicado: (2010)

Does the World Health Organization criterion adequately define glaucoma blindness?
por: Mokhles P, et al.
Publicado: (2017)

Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
por: Janulevičienė I, et al.
Publicado: (2012)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events
por: Tsumura T, et al.
Publicado: (2012)

Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]
por: Tsumura T, et al.
Publicado: (2013)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]
por: Tsumura T, et al.
Publicado: (2013)

Home-based visual field test for glaucoma screening comparison with Humphrey perimeter
por: Tsapakis S, et al.
Publicado: (2018)

Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost
por: Matsuura K, et al.
Publicado: (2013)